Bristol-Myers Squibb Company

Global biopharmaceutical company

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome.

Relationships Interlocks Giving Data

Leadership & Staff

1 / 12

John E Celentano

• SVP HR Public Affairs & Philan

Barak Barnoon Sr. Director, Bristol-Myers Squibb

• Senior Director ('15→?)*

John Jaresko

• senior territory business manager (Sep '14→?) [+1]

• territory business manager (Feb '03→Aug '14)

Anne Nielsen

• Chief Compliance & Ethics Off (Sep '13→?)

Paul von Autenried

• CIO (Jun '11→?) [+1]

• CIO ('12→?)

Giovanni Caforio President and CEO, Bristol-Myers Squibb Company

• President (Oct '11→?) [+1]

• President (?→'15)

Frances K Heller

• SVP (Oct '12→?)

Peter J Arduini President & CEO at GE HealthCare

• Director ('16→?)

Robert T Zito

• SVP

Jeremy M Levin Biopharmaceutical company executive

• SVP Strat Transactions (May '10→?)

Owners

Capital Income Builder, Inc.

• Institutional investor

Capital World Investors A privately owned investment manager. A DIVISION OF CAPITAL RESEARCH AND MANAGEMENT COMPANY

• Institutional investor

Board Members

1 / 2

Julia A Haller Opthalmologist-in-chief, Wills Eye Institute

• Board member ('19→?)

Lewis B Campbell former CEO, Textron | former interim CEO, Navistar

• Director ('99→?)

Thomas J Lynch Jr

• Board Member (Jan '14→?)

Michael W Bonney Executive chair of the board of Kaleido Buiosciences Inc; former President, Cubist Pharmaceuticals, Sudbury, Massachusetts

• Board member

Giovanni Caforio President and CEO, Bristol-Myers Squibb Company

• Board Member

Phyllis R Yale Partner, Bain & Company

• Board member ('19→?)

Lamberto Andreotti Chief Executive Officer, Bristol-Myers Squibb Company

• Board Member

James M Cornelius

• CEO [+2]

• Chairman

• Director

Charles A Heimbold Bristol-Myers Squibb

• chairman and CEO (past)

Elliott Sigal Former Executive Vice President & Chief Scientific Officer, Bristol-Myers Squibb

• Board Member (past)

Donations

Prostate Cancer Foundation The Prostate Cancer Foundation (PCF) was founded in 1993 to find better treatments and a cure for prostate cancer.

• Donation · 2,000,000 USD

Sunnybrook Foundation

• Donation · 250,000 CAD

Senate Independence Campaign Committee (SICC Housekeeping) "Housekeeping Account" of the Independent Democratic Conference

• Donation/Grant · 8,000 USD

Kim Thatcher Republican Senator District 13 Oregon

• Donation · 1,800 USD

Child Organizations

Bristol-Myers Squibb Pharmaceutical Group

• unit

Memberships

National Gay and Lesbian Chamber of Commerce

• Member

USMCA Coaliton Coalition that pushed for the passage of the USMCA

• Member

Bay Area Council A business-sponsored, public-policy advocacy organization for the nine-county Bay Area

• Member

Global Initiative to Standardize Fairness in the Trade of Data IEEE Initiative 2019

• Participant ('19→?)*

The Business Council of New York State, Inc. New York State business association

• member

Domestic Security Alliance Council Partnership between FBI, DHS, and private sector

• Leadership Board Member

Intellectual Property Committee A coalition of thirteen US corporations "dedicated to the negotiation of a comprehensive agreement on intellectual property in the current GATT round of multilateral trade negotiations".

• Member

PhRMA Represents research-based pharmaceutical and biotechnology companies in the US

• Member